Epileptic seizures after octreotide administration in a 65-year-old female with ALL and L-asparaginase associated pancreatitis: A possible drug interaction

Klinische Padiatrie

Volumn 223, Issue 6, 2011, Pages 360-363

  Hatzipantelis, E ^a   Pana, Z D ^a   Pavlou, E ^a   Balakou, E ^a   Tsotoulidou, V ^a   Papageorgiou, T ^a   Tragiannidis, A ^a   Athanassiadou, F ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

children; epileptic seizures; L asparaginase; octreotide; pancreatitis

Indexed keywords

ASPARAGINASE; DAUNORUBICIN; DIAZEPAM; ETIRACETAM; OCTREOTIDE; PHENYTOIN; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE PANCREATITIS; ARTICLE; CASE REPORT; CHILD; CONTINUOUS INFUSION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EPILEPSY; FEMALE; FRONTAL LOBE; HUMAN; PANCREATITIS; PRESCHOOL CHILD; RIGHT HEMISPHERE; TEMPORAL LOBE; TONIC CLONIC SEIZURE;

ACUTE DISEASE; ANTICONVULSANTS; ASPARAGINASE; CHILD; DIAGNOSIS, DIFFERENTIAL; DRUG INTERACTIONS; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMANS; OCTREOTIDE; PANCREATITIS; PIRACETAM; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 80755140497     PISSN: 03008630     EISSN: 14393824     Source Type: Journal    
DOI: 10.1055/s-0031-1287827     Document Type: Article

References (14)

1. Bulbul A, Unsur E K. Octreotid as a treatment of congenital chylothorax. Pediatr Pulmonol: 2010; 45 628
2. Cardoso A, Freitas-da-Costa P, Carvalho L S et al. Seizure-induced changes in neuropeptide Y-containing cortical neurons: Potential role for seizure threshold and epileptogenesis. Epilepsy Behav: 2010; 19 559 567
3. Earl M. Incidence and management of asparaginase-associated adverse events in patients with acute lymphoblastic leukemia. Clin Adv Hematol Oncol: 2009; 7 600 606
4. Flores-Caldern J, Exiga-Gonzalz E, Morn-Villota S et al. Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginase. J Pediatr Hematol Oncol: 2009; 31 790 793
5. Garrington T, Bensard D, Ingram J D et al. Successful management with octreotide of a child with L-asparaginase induced hemorrhagic pancreatitis. Med Pediatr Oncol: 1998; 30 106 109 (Pubitemid 128765925)
6. http://www.pharma.us.novartis.com/product/pi/pdf/sandostatin-inj.pdf
7. http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4399b1- 46%20%28Sandostatin%20%28octreotide%29%20Slides%20from%20April%202007%29.pdf
8. Knoderer H M, Robarge J, Flockhart D A. Predicting asparaginase- associated pancreatitis. Pediatr Blood Cancer: 2007; 49 634 639 (Pubitemid 350194426)
9. Laugel V, Escande B, Entz-Werle N et al. Severe acute pancreatitis in children receiving asparaginase: multicenter retrospective study. Arch Pediatr: 2005; 12 34 41
10. Pai V, Porter K, Ranalli M. Octreotide acetate is efficacious and safe in children for treating diarrhea due to chemotherapy but not acute graft versus host disease. Pediatr Blood Cancer: 2011; 56 45 49
11. Raetz E A, Salzer W L. Tolerability and efficacy of L-asparaginase therapy in pediatric patients with acute lymphoblastic leukemia. J Pediatr Hematol Oncol: 2010; 32 554 563
12. Tallent M K, Qiu C. Somatostatin: an endogenous antiepileptic. Mol Cell Endocrinol: 2008; 286 96 103
13. Wu S F, Chen A C, Peng C T et al. Octreotide therapy in asparaginase-associated pancreatitis in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer: 2008; 51 824 825
14. Tibussek D, Distelmaier F, Schnberger S et al. Antiepileptic treatment in paediatric oncology an interdisciplinary challenge. Klin Padiatr: 2006; 218 340 349 (Pubitemid 44862393)